Ledger.Open graph →
SEC Form D · Amendment · filed September 5, 2018

Trevi Therapeutics, Inc

Offering
$61.9M
Sold
$51.9M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
New Haven, CT
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Ed L. Mathers · New Haven, CTDirectorMette K. Agger · New Haven, CTDirectorCharles Casamento · BOCA RATON, FLDirectorTanya Campbell · Grand Cayman, Cayman IslandsExec · DirectorEran L. Nadav · New Haven, CTDirectorAnurag Kanungo · San Francisco, CADirectorAidan Madigan-Curtis · San Francisco, CAExecGordon H. Ip · Richardson, TXDirectorHerve Francois · New Hope, PAExec · DirectorCraig S. Hughes · Austin, TXExecSteve S. Oden, Jr · Austin, TXDirectorEd L. Mathers · New Haven, CTDirectorEran L. Nadav · New Haven, CTDirectorMette K. Agger · New Haven, CTDirectorChris K. Seiter · New Haven, CTExecAnnie L. Mitsak · New Haven, CTDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗